Researchers discover three specific drugs affect three different kinds of neurotransmitter receptors which all appear to play roles in Fragile X.
The NIH has launched three innovative projects which will focus on the development of therapeutics for nicotine addiction, AMD and Fragile X Syndrome.
Researchers have discovered how the Arc protein regulates neuronal activity, providing clues into the brain’s ability to form long-term memories.
Scientists have now identified a specific dysfunction in neuronal circuits that is caused by autism. The scientists also report about their success in reversing these neuronal changes in mouse models.
Using cyclocreatine, researchers successfully treated an autism spectrum disorder known as creatine transporter deficiency in a mouse model of autism.
Stem Cell Research Paves way for Progress on Dealing with Fragile X Retardation Researchers at the Hebrew University of Jerusalem have achieved, for the first time, the generation of neuronal cells from stem cells of Fragile X patients. The discovery paves the way for research that will examine restoration of normal gene expression in Fragile […]
A recently evolved pattern of gene activity in the language and decision-making centers of the human brain is missing in a disorder associated with autism and learning disabilities, a new study by Yale University researchers shows. “This is the cost of being human,” said Nenad Sestan, associate professor of neurobiology, researcher at Yale’s Kavli Institute for […]
A recent study finds that a new compound reverses many of the major symptoms associated with Fragile X syndrome (FXS), the most common form of inherited intellectual disability and a leading cause of autism. The paper, published by Cell Press in the April 12 issue of the journal Neuron, describes the exciting observation that the […]